Particle.news

Download on the App Store

CDC Finalizes Individual COVID-19 Guidance, Recommends Separate Chickenpox Shot for Children Under 4

The approval clears state and VFC ordering after delays that limited access for low-income children.

Overview

  • The agency updated adult and child immunization schedules to make COVID-19 vaccination a shared clinical decision for everyone 6 months and older, maintaining coverage but leaving prescription requirements for some settings unresolved.
  • For ages 12–36 months, varicella is now recommended as a standalone shot due to a small increase in febrile seizures with the combined MMRV product when used as the first dose; the combo remains acceptable for the second dose at ages 4–6.
  • Acting director Jim O’Neill signed off on Advisory Committee on Immunization Practices recommendations and said “Informed consent is back,” following the panel’s overhaul earlier this year by HHS Secretary Robert F. Kennedy Jr.
  • States can now order updated COVID-19 doses through the Vaccines for Children program, after a signing delay that left many VFC‑eligible children without access to this season’s shots.
  • Major medical groups including the American Academy of Pediatrics and the Infectious Diseases Society of America continue to advise vaccination for children, pregnant people and high‑risk adults, while reporting indicates some private plans may no longer be required to cover the MMRV product even as many insurers plan to cover COVID and flu vaccines through 2026.